Patents by Inventor Rand ARAFEH

Rand ARAFEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for the treatment of cancer
    Patent number: 11471504
    Abstract: An article of manufacture is disclosed which comprises: (i) a peptide agent which is capable of preventing extracellular signal-regulated kinase1/2 (ERK) translocation into the nucleus; and (ii) a MEK inhibitor. Uses thereof are also disclosed.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: October 18, 2022
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Yardena Samuels, Rand Arafeh, Karen Flores, Rony Seger, Ehud Wainstein
  • COMBINATION THERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20210154261
    Abstract: An article of manufacture is disclosed which comprises: (i) a peptide agent which is capable of preventing extracellular signal-regulated kinase1/2 (ERK) translocation into the nucleus; and (ii) a MEK inhibitor. Uses thereof are also disclosed.
    Type: Application
    Filed: July 24, 2018
    Publication date: May 27, 2021
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Yardena SAMUELS, Rand ARAFEH, Karen FLORES, Rony SEGER, Ehud WAINSTEIN